Status:
COMPLETED
The Role of Decortication in Complex Empyema Cases: Multidrug Resistance and Tuberculosis at the Forefront
Lead Sponsor:
University of Health Sciences Lahore
Conditions:
Pleural Empyema
Tuberculosis (TB)
Eligibility:
All Genders
Brief Summary
Empyema is a problem that thoracic surgeons deal in everyday practice. The main goal of treatment is evacuating the pus and fibrin deposits in the thoracic cavity for complete lung expansion. This stu...
Detailed Description
Pleural empyema, defined as the accumulation of infected pleural fluid, remains a significant clinical challenge globally despite advancements in medical and surgical therapies. In the United States, ...
Eligibility Criteria
Inclusion
- Patients diagnosed with pleural empyema based on clinical, radiological, and microbiological confirmation.
- Patients who underwent surgical decortication for complicated or refractory empyema.
Exclusion
- Patients with non-infectious pleural effusions (e.g., malignant pleural effusion, hemothorax, or chylothorax).
- Empyema cases resolved with medical management alone (antibiotics and/or chest tube drainage) without requiring surgical intervention.
- Patients with severe systemic conditions (e.g., end-stage organ failure, terminal malignancy) where empyema management was not the primary therapeutic focus.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
350 Patients enrolled
Trial Details
Trial ID
NCT07167823
Start Date
January 1 2022
End Date
August 31 2025
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Services Institute of Medical Sciences (SIMS), Services Hospital, Lahore
Lahore, Punjab Province, Pakistan, 54000